Clinical trial: Some sarcoma patients improve with T cell immunotherapy

by Julia Evangelou Strait,Washington University School of Medicine in St. LouisCredit: Pixabay from PexelsA clinical trial led by researchers at Washington University School of Medicine in St. L

Updated on: March 30,2024

Clinical trial: Some sarcoma patients improve with T cell immunotherapy

by Julia Evangelou Strait,Washington University School of Medicine in St. LouisCredit: Pixabay from PexelsA clinical trial led by researchers at Washington University School of Medicine in St. L

Updated on:March 30,2024

T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainSecond-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with t

Updated on: February 24,2024

T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainSecond-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with t

Updated on:February 24,2024

Researchers unlock mysteries of complex microRNA oncogenes

by McGill UniversityMicroRNA and mRNA visualization in differentiating C1C12 cells. Credit: Ryan Jeffs/WikipediaMicroRNAs are tiny molecules of nucleic acid that control gene expression, acting l

Updated on: June 11,2024

Researchers unlock mysteries of complex microRNA oncogenes

by McGill UniversityMicroRNA and mRNA visualization in differentiating C1C12 cells. Credit: Ryan Jeffs/WikipediaMicroRNAs are tiny molecules of nucleic acid that control gene expression, acting l

Updated on:June 11,2024

Metabolite from pomegranates improves the function of immune cells in their fight against cancer

byEcole Polytechnique Federale de LausanneGraphical abstract. Credit:Immunity(2022). DOI: 10.1016/j.immuni.2022.09.014Researchers from the Georg-Speyer-Haus in Frankfurt am Main, Ger

Updated on: January 04,2024

Metabolite from pomegranates improves the function of immune cells in their fight against cancer

byEcole Polytechnique Federale de LausanneGraphical abstract. Credit:Immunity(2022). DOI: 10.1016/j.immuni.2022.09.014Researchers from the Georg-Speyer-Haus in Frankfurt am Main, Ger

Updated on:January 04,2024

Scientists discover how excessive red meat consumption increases colorectal cancer risk

byAgency for Science, Technology and Research (A*STAR), SingaporeIdentification of SP2509 and its target Pirin as a regulator of hTERT in colorectal cancer. Credit:Cancer Discovery(2

Updated on: November 10,2024

Scientists discover how excessive red meat consumption increases colorectal cancer risk

byAgency for Science, Technology and Research (A*STAR), SingaporeIdentification of SP2509 and its target Pirin as a regulator of hTERT in colorectal cancer. Credit:Cancer Discovery(2

Updated on:November 10,2024

Identifying the underlying causes of ovarian cancer

byCedars-Sinai Medical CenterSimon Gayther, PhD, professor of Biomedical Sciences, and Michelle Jones, PhD, a research scientist in the Center for Bioinformatics and Functional Genomics, led the

Updated on: January 02,2024

Identifying the underlying causes of ovarian cancer

byCedars-Sinai Medical CenterSimon Gayther, PhD, professor of Biomedical Sciences, and Michelle Jones, PhD, a research scientist in the Center for Bioinformatics and Functional Genomics, led the

Updated on:January 02,2024

New insights into aggressive breast cancer and potential treatment options

by Marianne Lie Becker,University of Southern DenmarkThe findings made in the recent research projects. Credit: Professor Vijay Tiwari, University of Southern DenmarkTriple-negative breast cance

Updated on: April 06,2024

New insights into aggressive breast cancer and potential treatment options

by Marianne Lie Becker,University of Southern DenmarkThe findings made in the recent research projects. Credit: Professor Vijay Tiwari, University of Southern DenmarkTriple-negative breast cance

Updated on:April 06,2024

Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of

Updated on: April 23,2024

Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of

Updated on:April 23,2024

New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment

by Bob Yirka , Medical XpressScheme of genome editing of PDL1 by eOA effectively improved virotherapy and adoptive T-cell therapy. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-02

Updated on: March 05,2024

New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment

by Bob Yirka , Medical XpressScheme of genome editing of PDL1 by eOA effectively improved virotherapy and adoptive T-cell therapy. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-02

Updated on:March 05,2024

Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainChemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of cer

Updated on: January 22,2024

Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainChemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of cer

Updated on:January 22,2024

A new strategy to attack aggressive brain cancer shrank tumors in two early tests

by Lauran NeergaardThis combination of MRI scan images provided by theNew England Journal of Medicinein March 2024 shows the progress of a glioblastoma patient who received CAR-T therapy w

Updated on: March 20,2024

A new strategy to attack aggressive brain cancer shrank tumors in two early tests

by Lauran NeergaardThis combination of MRI scan images provided by theNew England Journal of Medicinein March 2024 shows the progress of a glioblastoma patient who received CAR-T therapy w

Updated on:March 20,2024

Discovery boosts the potential of new cancer-fighting drugs

by The Scripps Research InstituteCancer cell during cell division. Credit: National Institutes of HealthScientists at Scripps Research have uncovered a critical feature that a promising new class

Updated on: February 23,2024

Discovery boosts the potential of new cancer-fighting drugs

by The Scripps Research InstituteCancer cell during cell division. Credit: National Institutes of HealthScientists at Scripps Research have uncovered a critical feature that a promising new class

Updated on:February 23,2024